# High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

Study · id `cardio:ct-nct05912686` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05912686](<https://clinicaltrials.gov/study/NCT05912686>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05912686

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 162 participants.

## Technical summary

Registry record NCT05912686. Randomized; no masking; primary purpose treatment. Start 2023-07-01 (anticipated); primary completion 2025-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 162 participants (planned count; ClinicalTrials.gov record NCT05912686, source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)
- Planned start: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT05912686, source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)
- Primary completion: 2025-12-01 (anticipated) (ClinicalTrials.gov record NCT05912686, source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)
- Completion: 2026-07-31 (anticipated) (ClinicalTrials.gov record NCT05912686, source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05912686, source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05912686-2023-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients
- Condition: Mechanical Thrombectomy
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Atorvastatin 80mg
- Intervention (Drug): Atorvastatin 20mg
- Lead sponsor: Zhongda Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Zhongda Hospital (`cardio:org-zhongda-hospital`)

## Provenance

Content hash: a1a6b99a31d76469035b03a4d641983e94f8da38b9a40d4b6adc5a464ce9701d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
